News

The Pharma Letter9h
ALK Abello inks neffy co-promotion deal in USA
Danish allergy immunotherapy specialist ALK Abello (OMX: ALK B) has announced a four-year agreement with USA-based ARS ...
The Pharma Letter10h
HHS and NIH launch vaccine platform for pandemic-prone viruses
The US Department of Health and Human Services (HHS) and the National Institutes for Health (NIH) have announced a $500 ...